Japan Lifeline

JLFNF · TOKYO

Price unavailable right now.

No price history for this range.

About JLFNF

Japan Lifeline Co., Ltd. engages in the import, development, production, and distribution of medical devices. The company is headquartered in Shinagawa-Ku, Tokyo-To and currently employs 1,250 full-time employees. The firm's products include cardiac pacemakers, implantable cardioverter defibrillators (ICDs), and biventricular pacemakers with defibrillation function (CRT-Ds) used to treat cardiac arrhythmias, electrophysiology (EP) catheters used to examine cardiac arrhythmias, ablation catheters used to treat arrhythmias, artificial blood vessels, frozen elephant trunks, and stent grafts used to treat aortic diseases, embolization coils, thrombus aspiration catheters, and stent retrievers used in cerebrovascular treatment, as well as colonic stents, gastric and duodenal stents used to treat digestive diseases, radiofrequency ablation electrode needles for the treatment of liver cancer, and bile duct tube stents.

Employees
1,250
Headquarters
Shinagawa-ku, Tokyo-To
Listed
Dec 8, 1997
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
jll.co.jp

JLFNF key statistics

This section is temporarily unavailable. Refresh to try again.

JLFNF earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 8 quarters, by 7.6% on average.

  1. Q1 FY21: reported $10.54 per share against an estimate of $15.68
  2. Q2 FY21: reported $24.14 per share against an estimate of $26.00
  3. Q3 FY21: reported -$31.59 per share against an estimate of $32.82
  4. Q4 FY21: reported $21.82 per share against an estimate of $25.52
  5. Q1 FY22: reported $21.18 per share against an estimate of $19.68
  6. Q2 FY22: reported $23.49 per share against an estimate of $29.19
  7. Q3 FY22: reported $24.01 per share against an estimate of $31.21
  8. Q4 FY22: reported $24.45 per share against an estimate of $26.55

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.